Hydroxyethyl Starch (HES) [130/0.4], a New HES Specification: Pharmacokinetics and Safety after Multiple Infusions of 10% Solution in Healthy Volunteers

By Waitzinger J.  

Drugs in R&D, Vol. 4, Iss. 3, 2003-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Metabolism and Disposition of [14C]XQ-1H After Intravenous Administration to Male Rats

By  

Drug Metabolism Letters, Vol. 10, Iss. 4, 2017-03 ,pp. : 228-239

Bentham Science Publishers

Access to resources Recommend Favorite

PHARMACOKINETIC DISPOSITION AND TISSUE DISTRIBUTION OF BISPHENOL A IN RATS AFTER INTRAVENOUS ADMINISTRATION

By Yoo Sun Dong   Shin Beom Soo   Kwack Seung Jun   Lee Byung Mu   Park Kui Lea   Han Soon-Young   Kim Hyung Sik  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 2, 2000-09 ,pp. : 131-139

Taylor & Francis Ltd

Access to resources Recommend Favorite